主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
QURE
#2065
uniQure N.V. - Ordinary Shares
27.3
0
USD
+3.21%
版块:
医疗保健
基础:
USD
利润货币:
USD
日范围
年范围
日变化
+3.21%
每月变动
+0.52%
6个月变化
+26.80%
年变化
+55.64%
前一天收盘价
26.4
5
Open
27.0
0
最低价
26.8
3
High
27.4
0
交易量
84
市场
US Stock Market
医疗保健
QURE
1W
1M
3M
6M
YTD
1Y
5Y
展开完整图表
Financials
概览
声明
统计
每季度
年度
Market Capitalization
1.72 B
Employee
221
Founded
1998
CEO
Matt Kapusta
Website
www.uniqure.com
Headquarter
Netherlands
FIGI
UNKNOWN
Industry
生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-4.68
市销率
52.26
uniQure N.V. - Ordinary Shares
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies.
新闻
uniQure: Why A Shifting FDA Could Change Everything For AMT-130 (NASDAQ:QURE)
Biotech Investors Are Tuning Out the MAHA Chaos
uniQure (QURE) Reports Q1 Loss, Misses Revenue Estimates
Kyverna Therapeutics: 'Strong Buy' On Additional POC Of Miv-Cel In Myasthenia Gravis
Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?
uniQure Investors Sue Company Over Huntington’s Disease Drug Study Claims - TipRanks.com
Biotechs Breathe Easy As Vinay Prasad Plans His Exit. But Should They?
PGIM Jennison Health Sciences Fund Q4 2025 Key Contributors And Detractors
A Unique Situation For UniQure (QURE)
瑞穗因FDA领导层变动上调uniQure股票评级
Mizuho upgrades uniQure stock rating on FDA leadership change
Avago, Lumentum among market cap stock movers on Monday